Wikidata

(Q44370429)

English

A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer

scientific article published in June 2012

In more languages

Statements

title
A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017
author name string
Peter M Ellis
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017
Quincy S Chu
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017
Natasha Leighl
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017
Scott A Laurie
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017
Holger Fritsch
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017
Birgit Gaschler-Markefski
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017
Steve Gyorffy
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017
Gerd Munzert
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
22658814
retrieved
2 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44370429&oldid=2165619477"